Answers are grounded in this paper and cite their sources.
In this month's issue of the Journal, Tabor et al.1 make a case for centralization of amniocentesis and chorionic villus sampling (CVS) services. Their data show that units carrying out more than 136 procedures per annum (>1500 in 11 years) have lower miscarriage rates compared with less busy units. They suggest that, in any given unit, even 150 procedures per year may not be sufficient to maintain expertise, particularly if units have a duty to educate new operators. Current UK guidelines take a slightly different approach and focus on performance of the individual rather than the unit: ‘At present, therefore, it is not possible to make evidence based recommendations on the number of procedures that should be carried out annually to maintain competency. An arbitrary number of at least ten procedures per annum seems reasonable. However, further research is needed to clarify whether adequately trained operators should be deemed unsafe just because they failed to reach a certain threshold in the number of performed procedures.’2. Other national guidelines have, by and large, avoided the issue of competency3, 4. As the number of invasive prenatal procedures continues to decline with the introduction of more sophisticated screening tests, it will be increasingly difficult to avoid the issue of competency. It is simply stating the obvious that, when it comes to any skill—surgical or otherwise—talent and dexterity have to be complemented with regular practice to guarantee success. Ultrasound-guided invasive procedures are no exception and several experienced operators have been reporting remarkably low pregnancy loss rates5, 6. However, meticulous follow-up is very time consuming and expensive. Small units have no incentive to provide safety data, but, as most healthcare systems are calling for revalidation, the onus will be on the operators to prove that their skills are adequate. Competency will have to be demonstrated by the hard data on complications (dry tap, multiple insertions, any post-procedure pregnancy loss) and for most small practices and occasional operators this may be more trouble than it's worth. High-quality medical care is not just a series of diagnostic and therapeutic procedures performed by the best in the business. The calls for centralization of medical services, as a rule, come from highly specialized tertiary centers that feel threatened by smaller teams providing the close-to-home, personalized care that is so highly valued by patients. Having ‘monopolized’ the evidence and guidelines that stem from such evidence, super-specialists are determined to scare the public into thinking that only centralized services are safe. Surely, a single parameter—number of procedures per annum—cannot be a guarantor of quality. Well-trained and skilled ‘generalists’ who perform procedures well, but infrequently, should be allowed to prove to both their patients and authorities, that they have an important role to play in the provision of high-quality obstetric care. When it comes to fetal medicine skills (diagnosis of fetal anomalies, nuchal translucency measurements, invasive procedures), unit-based data should be regarded as obsolete. The time has come to focus on individual performance. The Fetal Medicine Foundation nuchal translucency monitoring program has set the benchmark upon which we need to build. However, for ultrasound-guided invasive procedures, a ‘one-size-fits-all’ approach will not work. A new update of the Royal College of Obstetricians and Gynaecologists amniocentesis and CVS guidelines proposes a minimum of 30 invasive procedures per annum per operator. Such high-volume operators should keep a record of their performance, including rate of pregnancy loss at any gestational age after the procedure, proportion of procedures requiring multiple insertions, proportion of procedures with failure to obtain an adequate sample and complications such as ‘bloody’ tap and amniotic fluid leakage. It is relatively straightforward to set up target rates and to prospectively monitor one's performance7. This can be adjusted for lower-volume operators. In Figure 1, we have used amniocentesis to demonstrate how simple statistical process control charts can be used for this purpose. Multiple needle insertion (MNI) as a monitoring tool for amniocentesis performance. The local benchmark was set at 3% () and Operator D is above the action limit set outside 95% CI (). Alert line was set at 90% CI (). Further action is required to ascertain the reason for this poor performance. Reproduced with permission from Lane et al.7. Clearly, any such quality and safety measures, when publicly available, have to be accurate and precise to avoid unfair stigmatization and loss of trust due to unfounded and often counterproductive external judgments8. The real challenge is to ensure that such monitoring stimulates and supports internal learning, which is the key for quality and patient safety.
No takes yet. Share an insight, caveat, or question.
Žarko Alfirević (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: